Quick Answer
Elevance Health, Inc. reported Stockholders Equity of $43.88 billion for the year ending 2025.
- Elevance Health, Inc. showed an increase of +6.2% in Stockholders Equity from 2024 to 2025.
- This data is from Elevance Health, Inc.'s annual report (Form 10-K), filed with the SEC on February 6, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2011: $23.98 billion | Q2 2011: $24.18 billion | Q3 2011: $23.72 billion | Q1 2012: $23.53 billion | Q2 2012: $23.64 billion | Q3 2012: $23.82 billion | Q1 2013: $24.32 billion | Q2 2013: $24.53 billion | Q3 2013: $24.81 billion | Q1 2014: $24.35 billion | Q2 2014: $24.38 billion | Q3 2014: $24.29 billion | Q1 2015: $24.33 billion | Q2 2015: $23.06 billion | Q3 2015: $23.24 billion | Q1 2016: $23.55 billion | Q2 2016: $24.23 billion | Q3 2016: $24.74 billion | Q1 2017: $26.09 billion | Q2 2017: $26.43 billion | Q3 2017: $25.95 billion | Q1 2018: $27.01 billion | Q2 2018: $28.73 billion | Q3 2018: $29.09 billion | Q1 2019: $30.00 billion | Q2 2019: $30.79 billion | Q3 2019: $31.33 billion | Q1 2020: $31.69 billion | Q2 2020: $34.46 billion | Q3 2020: $33.92 billion | Q1 2021: $33.85 billion | Q2 2021: $34.97 billion | Q3 2021: $35.81 billion | Q4 2021: $36.10 billion | Q1 2022: $35.98 billion | Q2 2022: $35.81 billion | Q3 2022: $36.06 billion | Q1 2023: $37.36 billion | Q2 2023: $38.21 billion | Q3 2023: $38.42 billion | Q1 2024: $40.61 billion | Q2 2024: $42.19 billion | Q3 2024: $43.78 billion | Q1 2025: $42.50 billion | Q2 2025: $43.72 billion | Q3 2025: $43.95 billion.
- Over the full 17 years of available data (2009 to 2025), Elevance Health, Inc.'s Stockholders Equity has grown by 76.5%.
- Historical annual values: Fiscal year 2025: $43.88 billion | Fiscal year 2024: $41.32 billion | Fiscal year 2023: $39.31 billion | Fiscal year 2022: $36.24 billion | Fiscal year 2021: $36.06 billion | Fiscal year 2020: $33.20 billion | Fiscal year 2019: $31.73 billion | Fiscal year 2018: $28.54 billion | Fiscal year 2017: $26.50 billion | Fiscal year 2016: $25.10 billion | Fiscal year 2015: $23.05 billion | Fiscal year 2014: $24.25 billion | Fiscal year 2013: $24.77 billion | Fiscal year 2012: $23.80 billion | Fiscal year 2011: $23.29 billion | Fiscal year 2010: $23.81 billion | Fiscal year 2009: $24.86 billion.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: